Yuhan Corporation (000105.KS)
KRW 101900.0
(-3.04%)
KRW 101900.0
(-3.04%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 564.5 Billion KRW | 14.98% |
| 2022 | 518.2 Billion KRW | -1.23% |
| 2021 | 524.65 Billion KRW | -6.05% |
| 2020 | 558.42 Billion KRW | 29.61% |
| 2019 | 430.85 Billion KRW | 4.12% |
| 2018 | 413.79 Billion KRW | -2.55% |
| 2017 | 424.62 Billion KRW | 9.03% |
| 2016 | 389.44 Billion KRW | 14.32% |
| 2015 | 340.66 Billion KRW | 8.0% |
| 2014 | 315.43 Billion KRW | 7.37% |
| 2013 | 293.77 Billion KRW | 19.63% |
| 2012 | 245.56 Billion KRW | -2.95% |
| 2011 | 253.04 Billion KRW | -8.21% |
| 2010 | 275.67 Billion KRW | -4.7% |
| 2009 | 289.28 Billion KRW | -0.67% |
| 2008 | 291.22 Billion KRW | 19.56% |
| 2007 | 243.58 Billion KRW | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 211.58 Billion KRW | -1.08% |
| 2024 Q1 | 168.96 Billion KRW | -61.35% |
| 2023 Q4 | 437.15 Billion KRW | 202.54% |
| 2023 FY | 595.83 Billion KRW | 14.98% |
| 2023 Q1 | 135.56 Billion KRW | -0.44% |
| 2023 Q2 | 152.81 Billion KRW | 12.73% |
| 2023 Q3 | 144.49 Billion KRW | -5.45% |
| 2022 FY | 518.2 Billion KRW | -1.23% |
| 2022 Q2 | 145.43 Billion KRW | 25.56% |
| 2022 Q1 | 115.83 Billion KRW | -14.69% |
| 2022 Q4 | 136.16 Billion KRW | 12.76% |
| 2022 Q3 | 120.75 Billion KRW | -16.97% |
| 2021 Q1 | 114.97 Billion KRW | -35.12% |
| 2021 Q2 | 141.14 Billion KRW | 22.76% |
| 2021 FY | 524.65 Billion KRW | -6.05% |
| 2021 Q3 | 132.75 Billion KRW | -5.94% |
| 2021 Q4 | 135.77 Billion KRW | 2.27% |
| 2020 Q1 | 91.36 Billion KRW | -26.05% |
| 2020 Q3 | 136.29 Billion KRW | -11.24% |
| 2020 Q4 | 177.2 Billion KRW | 30.02% |
| 2020 FY | 558.42 Billion KRW | 29.61% |
| 2020 Q2 | 153.55 Billion KRW | 68.07% |
| 2019 Q4 | 123.54 Billion KRW | 17.54% |
| 2019 Q2 | 98.93 Billion KRW | -4.19% |
| 2019 Q1 | 103.26 Billion KRW | -3.03% |
| 2019 FY | 430.85 Billion KRW | 4.12% |
| 2019 Q3 | 105.1 Billion KRW | 6.24% |
| 2018 Q2 | 108.98 Billion KRW | 7.04% |
| 2018 FY | 413.79 Billion KRW | -2.55% |
| 2018 Q4 | 106.49 Billion KRW | 10.35% |
| 2018 Q3 | 96.49 Billion KRW | -11.46% |
| 2018 Q1 | 101.81 Billion KRW | 1.74% |
| 2017 Q4 | 100.07 Billion KRW | -5.21% |
| 2017 FY | 424.62 Billion KRW | 9.03% |
| 2017 Q1 | 109.31 Billion KRW | 4.61% |
| 2017 Q2 | 109.66 Billion KRW | 0.32% |
| 2017 Q3 | 105.57 Billion KRW | -3.73% |
| 2016 Q1 | 83.04 Billion KRW | -6.26% |
| 2016 Q2 | 100.64 Billion KRW | 21.19% |
| 2016 Q3 | 101.25 Billion KRW | 0.61% |
| 2016 FY | 389.44 Billion KRW | 14.32% |
| 2016 Q4 | 104.49 Billion KRW | 3.2% |
| 2015 Q3 | 96.73 Billion KRW | 13.6% |
| 2015 Q4 | 88.59 Billion KRW | -8.41% |
| 2015 FY | 340.66 Billion KRW | 8.0% |
| 2015 Q1 | 70.17 Billion KRW | -18.57% |
| 2015 Q2 | 85.15 Billion KRW | 21.34% |
| 2014 Q1 | 68.5 Billion KRW | -16.22% |
| 2014 FY | 315.43 Billion KRW | 7.37% |
| 2014 Q4 | 86.18 Billion KRW | 9.65% |
| 2014 Q3 | 78.6 Billion KRW | -4.31% |
| 2014 Q2 | 82.14 Billion KRW | 19.92% |
| 2013 Q3 | 66.96 Billion KRW | -13.6% |
| 2013 Q4 | 81.76 Billion KRW | 22.09% |
| 2013 FY | 293.77 Billion KRW | 19.63% |
| 2013 Q1 | 67.53 Billion KRW | 5.46% |
| 2013 Q2 | 77.51 Billion KRW | 14.78% |
| 2012 Q2 | 63.87 Billion KRW | 14.79% |
| 2012 Q1 | 55.64 Billion KRW | 0.0% |
| 2012 Q3 | 61.06 Billion KRW | -4.4% |
| 2012 Q4 | 64.03 Billion KRW | 4.87% |
| 2012 FY | 245.56 Billion KRW | -2.95% |
| 2011 Q1 | 65.38 Billion KRW | 2.14% |
| 2011 FY | 253.04 Billion KRW | -8.21% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 60.8 Billion KRW | -7.71% |
| 2011 Q2 | 65.88 Billion KRW | 0.77% |
| 2010 Q3 | 61.96 Billion KRW | -13.45% |
| 2010 Q2 | 71.59 Billion KRW | 3.54% |
| 2010 Q1 | 69.14 Billion KRW | 3.58% |
| 2010 Q4 | 64.01 Billion KRW | 3.3% |
| 2010 FY | 275.67 Billion KRW | -4.7% |
| 2009 Q3 | 65.36 Billion KRW | -8.71% |
| 2009 Q4 | 66.76 Billion KRW | 2.13% |
| 2009 FY | 289.28 Billion KRW | -0.67% |
| 2009 Q1 | 68.88 Billion KRW | 6.89% |
| 2009 Q2 | 71.6 Billion KRW | 3.95% |
| 2008 Q4 | 64.44 Billion KRW | -6.53% |
| 2008 FY | 291.22 Billion KRW | 19.56% |
| 2008 Q1 | 66.17 Billion KRW | 15.99% |
| 2008 Q2 | 72.44 Billion KRW | 9.48% |
| 2008 Q3 | 68.94 Billion KRW | -4.83% |
| 2007 FY | 243.58 Billion KRW | 0.0% |
| 2007 Q1 | 50.67 Billion KRW | 0.0% |
| 2007 Q2 | 61.19 Billion KRW | 20.75% |
| 2007 Q3 | 58.78 Billion KRW | -3.94% |
| 2007 Q4 | 57.05 Billion KRW | -2.94% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -1113.865% |
| Dong-A Socio Holdings Co., Ltd. | 364.1 Billion KRW | -55.039% |
| Ildong Holdings Co., Ltd. | 198.88 Billion KRW | -183.834% |
| HANDOK Inc. | 151.36 Billion KRW | -272.942% |
| Kukje Pharma Co., Ltd. | 67.22 Billion KRW | -739.736% |
| Dong-A ST Co., Ltd. | 322.21 Billion KRW | -75.198% |
| SAMSUNG PHARM. Co., LTD. | 23.74 Billion KRW | -2277.172% |
| Hanmi Pharm. Co., Ltd. | 835.85 Billion KRW | 32.463% |
| Hanall Biopharma Co.,Ltd | 75.03 Billion KRW | -652.282% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | -183.727% |
| Dong Sung Bio Pharm.Co.,Ltd. | 40.64 Billion KRW | -1288.719% |
| MYUNGMOON Pharm co.,Ltd | 94.51 Billion KRW | -497.266% |
| Hana Pharm Co., Ltd. | 140.85 Billion KRW | -300.771% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -1113.865% |
| Ilsung Pharmaceuticals Co., Ltd. | 34.71 Billion KRW | -1526.087% |
| REYON Pharmaceutical Co., Ltd. | 76.81 Billion KRW | -634.862% |
| Aprogen pharmaceuticals,Inc. | -12.04 Billion KRW | 4786.427% |
| JW Holdings Corporation | 446.15 Billion KRW | -26.527% |
| Ildong Pharmaceutical Co., Ltd. | 207.53 Billion KRW | -172.001% |
| Chong Kun Dang Pharmaceutical Corp. | 655.34 Billion KRW | 13.861% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | -68.173% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -618.024% |
| Hyundai Pharmaceutical Co., Ltd. | 75.23 Billion KRW | -650.297% |
| Samil Pharmaceutical Co.,Ltd | 72.21 Billion KRW | -681.743% |
| Jeil Pharmaceutical Co.,Ltd | 183.81 Billion KRW | -207.108% |
| Yuyu Pharma, Inc. | 46.5 Billion KRW | -1113.865% |
| Kwang Dong Pharmaceutical Co., Ltd. | 295.11 Billion KRW | -91.282% |
| Daewoong pharmaceutical Co.,Ltd | 681.55 Billion KRW | 17.173% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | -68.173% |
| Yuhan Corporation | 564.5 Billion KRW | 0.0% |
| Jeil Pharma Holdings Inc | 201.82 Billion KRW | -179.707% |
| Yungjin Pharm. Co., Ltd. | 70.93 Billion KRW | -695.766% |
| Suheung Co., Ltd. | 99.02 Billion KRW | -470.055% |
| JW Pharmaceutical Corporation | 335.67 Billion KRW | -68.173% |
| Samjin Pharmaceuticals Co., Ltd. | 145.89 Billion KRW | -286.937% |
| Korea United Pharm Inc. | 173.48 Billion KRW | -225.388% |
| CKD Bio Corp. | 5.01 Billion KRW | -11166.961% |
| Daewon Pharmaceutical Co., Ltd. | 254.23 Billion KRW | -122.045% |
| Dongwha Pharm.Co.,Ltd | 184.12 Billion KRW | -206.591% |
| Whan In Pharm Co.,Ltd. | 98.12 Billion KRW | -475.293% |
| Shin Poong Pharm.Co.,Ltd. | 78.61 Billion KRW | -618.024% |
| Chong Kun Dang Holdings Corp. | 371.49 Billion KRW | -51.955% |
| Boryung Corporation | 333.26 Billion KRW | -69.385% |
| Bukwang Pharmaceutical Co., Ltd. | 50.04 Billion KRW | -1027.991% |
| Ilyang Pharmaceutical Co.,Ltd | 198.96 Billion KRW | -183.727% |
| JW Lifescience Corporation | 51.32 Billion KRW | -999.872% |